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Summary. Earlier we reported that atherosclerotic 
lesions of apoE-deficient mice contained cells which 
stained positively with anti-S-100 antibody and that cells 
exhibiting the ultrastructural features of dendritic cells 
were present in the aortic lesions. These observations 
suggested that dendritic cells might be involved in 
mouse atherosclerosis. By employing DEC-205 and 
MIDC-8 antibodies specific for dendritic cells, the 
present study has established that dendritic cells indeed 
accumulate in atherosclerotic lesions of apoE-deficient 
mice. Finding dendritic cells infiltrating atherosclerotic 
lesions in apoE-deficient mice offers the possibility of 
investigating the migratory routes of dendritic cells and 
their involvement in T-cell activation. 
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lntroduction 
Dendritic cells constitute a family of cells able to 
induce primary immune responses (Banchereau and 
Steinman, 1998; Lotze and Thomson, 1999). They are 
thought to arise from a common CD34+ progenitor in 
the bone marrow from where they migrate via the blood 
stream to settle in different peripheral tissues 
(Banchereau and Steinman, 1998; Lotze and Thomson, 
1999). After engulfing antigen, dendritic cells migrate 
via afferent lymph to activate T-cells (Banchereau and 
Steinman, 1998; Lotze and Thomson, 1999). Dendritic 
cells express high levels of both class 1 and class 11 
MHC molecules and co-stimulatory molecules which 
explains their unique ability to activate naive T-cells 
(Banchereau and Steinman, 1998; Lotze and Thomson, 
1999). 
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Using cell-type specific antibodies, we found that in 
man, dendritic cells reside in the normal non-diseased 
arteries and become activated during atherogenesis 
(Bobryshev and Lord, 1995, 1999; Bobryshev et al., 
1997; Lord and Bobryshev, 1999; Bobryshev, 2000). 
Some dendritic cells cluster with T-cells directly within 
human atherosclerotic lesions while others are thought to 
migrate to regional lymph nodes to activate T-cells 
(Bobryshev and Lord, 1998; Bobryshev, 2000). 
Investigating dendritic cells in atherosclerosis has been 
limited, however, because the presence of dendritic cells 
in the artery wall has been proved only in human 
specimens obtained at operations and post-mortem 
(Bobryshev and Lord, 1995, 1998, 1999; Bobryshev et 
al., 1997; Lord and Bobryshev, 1999). 
To further our understanding of the significance of 
dendritic cells in atherosclerosis, an animal experimental 
model is necessary. ApoE-deficient mice represent one 
of such popular models as apoE-deficient mice develop 
advanced atherosclerotic plaques with features 
characteristic of those seen in humans, including the 
formation of a necrotic core and calcification 
(Nakashima et al., 1994; Reddick et al., 1994). Earlier 
we reported that atherosclerotic lesions in apoE-deficient 
mice contain cells which stain positively with anti-S-100 
antibody (Bobryshev et al., 1999a). Unfortunately, anti- 
S-100 antibody is not specific for dendritic cells since 
this antibody stains a variety of cell types (Zimmer et al., 
1995; Lotze and Thomson, 1999). The detection of S- 
100+ cells in atherosclerotic lesions of apoE-deficient 
mice therefore did not prove that the positively stained 
cells were dendritic cells even though cells exhibiting 
the ultrastructural features of dendritic cells were 
detected in apoE-deficient mouse aortic lesions by 
electron-microscopic examination (Bobryshev et al., 
1999b). 
Very recently, specific antibodies to mouse dendritic 
cells became commercially available. By employing 
these antibodies, the present study aimed to determine 
whether dendritic cells indeed accumulate in 
atherosclerotic lesions of apoE-deficient mice. 
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Materials and methods 
Aortic specimens 
For this study arterial samples were obtained from 
10 apoE-deficient C57BL16X129 rnice rnaintained in 
microisolator cages on the PMI autoclavable rodent diet 
No. 5010 for eight months. Al1 the procedures were 
carried out in accordance with the institutional 
guidelines for laboratory animal care. The mice were 
anaesthetised with rnethoxyfluorane. Macroscopical 
examination showed that the aortas contained well 
developed atherosclerotic plaques as well as early 
intima1 lesions surrounded by non-diseased segments of 
the arterial wall. For histological and immunohisto- 
chemical analyses, aortic segrnents were taken from the 
region of the proximal aorta (ascending aorta and arch). 
Non-fixed tissue sarnples and the samples fixed in 
periodate-lysine-paraformaldehyde solution were 
embedded in OCT cornpound Tissue-Tek 11 (Miles 
Laboratories) as previously described (Bobryshev et al., 
1997). Small tissue samples were fixed in 2.5% 
glutaraldehyde in 0.1M cacodilate buffer (pH 7.4) for 
electron microscopic exarnination. 
Antibodies 
DEC-205 (NLDC-145) and MIDC-8 are specific 
antibodies for identifying mouse dendritic cells (Kraal et 
al., 1986; Breel et al., 1987; Jiang et al., 1995; Swiggard 
et al., 1995; Inaba et al., 1995). In the present study 
DEC-205 (NLDC-145) and MIDC-8 antibodies we used, 
both purchased frorn Serotec. NLDC-145 recognises 
DEC-205, a 205-kDa integral membrane glycoprotein 
expressed at high levels by mouse dendritic cells (Kraal 
et al., 1986; Breel et al., 1987; Jiang et al., 1995; 
Swiggard et al., 1995; Inaba et al., 1995). The antigen 
DEC-205 has been found on Ia+ interdigitating cells in 
T-cell areas of al1 secondary lyrnphoid organs and is 
present on veiled cells. In non-lymphoid organs, the 
antigen has been identified on Langerhans cells in the 
rnouse skin. DEC-205 is absent in bone rnarrow cells as 
well as in non-dendritic blood cells (Kraal et al., 1986; 
Breel et al., 1987; Jiang et al., 1995; Inaba et al., 1995: 
Swiggard et al., 1995). Another antibody, MIDC-8, 
recognises the antigen located in the cytoplasm of rnouse 
dendritic cells (Breel et al., 1987). This antigen is 
present in interdigitating cells in T-cell dependent areas 
of secondary lymphoid organs, the medulla of the 
thymus, veiled cells, and a small content was identified 
in Langerhans cells. MIDC-8 antigen is absent from 
non-dendritic blood cells and macrophages (Breel et al., 
1987). In the present study, both the rat anti-mouse 
DEC-205 antibody and rat anti-mouse dendriticl 
interdigitating cell antibody (MIDC-8) were used in a 
dilution 1:10 according to the manufacturer's 
recommendations. 
Anti-CD3 (PharMingen; 500A2; Dilution 1:lO) was 
used for identifying T-cells. Antibody MOMA-2 
(Serotec; Dilution 1:20) was used to identify 
rnacrophages. Srnooth muscle cells were stained with 
anti-a-smooth rnuscle actin (Sigma Immunochemicals; 
Dilution 1:60). 
lmmunohistochemical procedures 
The presence of dendritic cells was examined using 
biotin-streptavidin and 3-amino-9 ethylcarbazole (AEC) 
substrate-chrornogen systern (Dako) which produces a 
red staining of antigens. In brief, after blocking 
endogenous peroxidase with 0.3% hydrogen peroxide 
and treatment with an appropriate normal serum, frozen 
sections were incubated with an appropriate biotinalated 
secondary antibody and peroxidase-conjugated 
streptavidin (Dako) as described earlier (Bobryshev et 
al., 1997). The peroxidase-oxidase reaction was 
developed with AEC substrate kit. Al1 
immunohistochernical procedures were carried out at 
room ternperature. For positive control, mouse spleen 
tissue was used. For negative controls, the first antibody 
was omitted or the sections were treated with an 
irnrnunoglobulin fraction of non-immune goat serurn as 
a substitute for the prirnary antibody. None of the 
negative control sections showed positive imrnune 
staining. Counterstaining was perforrned with Mayer's 
haernatoxylin. 
Electron microscopy 
For electron rnicroscopic analysis, the aortic sarnples 
were fixed in 2.5% glutaraldehyde in 0.1M cacodilate 
buffer (pH 7.4), postfixed in 1% osmium tetroxide in 
cacodilate buffer, dehydrated in graded ethanol and 
propylene oxide and then embedded in Araldite resin. 
Serial ultrathin sections were cut on a LKB-111 
ultratome. Ultrathin sections were stained with uranyl 
acetate and lead citrate and examined with the aid of a 
Hitachi H7000 electron microscope at an accelerating 
voltage of 75 kv. 
Results 
Histological data 
Histological exarnination showed the presence of 
rnultiple atherosclerotic lesions surrounded by non- 
altered segrnents of the aortic wall. The atherosclerotic 
lesions were represented by a variety of both early and 
well-developed plaques. The atherosclerotic lesions 
contained large amounts of lipids visualised by staining 
with oil red 0 ,  the lesion structures corresponding to 
those described by us earlier (Bobryshev et al., 1999a). 
Histochemical obsetvations 
Aortic sections stained with DEC-205 antibody 
contained no immunopositive cells in non-diseased parts 
of the vessels (Fig. 1A) but DEC-209 cells were present 
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in the subendothelial space in intimal thickenings (Fig. 
lB,C). These positively stained cells were usually 
spindle-shaped in section and were spread along the 
interna1 basa1 lamina (Fig. lB,C). DEC-205+ cells were 
detected in al1 the aortas studied. 
To see whether DEC-205+ cells might originate from 
the blood stream, we specifically looked for DEC-205+ 
cells attached to the luminal endothelial surface and 
these cells were indeed found. They were observed in 
areas of swollen intima (Fig. ID) but there were no 
DEC-205+ cells attached to the endothelium in non- 
diseased segments of aortas. DEC-205+ cells attached to 
the luminal surface of atherosclerotic lesions exhibited a 
round or oval shape (Fisg. ID, 2A) and their penetration 
of swollen intima was observed (Fig. 2A). Within the 
atherosclerotically altered aortic segments, oval- and 
irregularly-shaped DEC-205+ cells were detected not 
only in the intima but in both the media (Fig. 2B) and 
the adventitia (Fig. 2C) as well. 
By reconstructive analysis of serial sections of 
advanced atherosclerotic lesions, we estimated that more 
than 80% of plaques contained DEC-209 cells. In 
Flg. l. ldentification of dendritic cells with DEC-205 antibody in the aortic wall of apoE-deficient mice. A. 3ased segment showing no 
immunopositivity for DEC-205 antibody. B and C. DEC-205+ cells (arrows) located along the endothelium in intimal thickenings. D. Small arrows show 
DEC-205+ cells attached to the luminal surface of an intimal thickening (stars) while large arrows show DEC-205+ cells attached to the surface of an 
atherosclerotic plaque (asterisk). L: lumen of the aorta. lmmunoperoxidase technique; visualisation was produced with AEC substrate kit; 
counterstaining with Mayer's haematoxylin. x 400 
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general, more DEC-209 cells were seen attached to the 
luminal surface in the aortic segments containing 
atherosclerotic plaques than in those with intimal 
thickenings (Figs. I D ,  2D). Along the surface of 
atherosclerotic plaques, DEC-205+ cells formed clusters 
(Fig. 2D,E). Some clustering, round-shaped DEC-205+ 
cells seemed to be only slightly attached to the plaque 
surface through fibrin-like material while others were 
spread out on the plaque luminal surface (Figs. 2D, 3A). 
Within atherosclerotic plaques, there were more 
DEC-205+ cells than in intimal thickenings (Fig. 1C vs 
Fig. 3B) and DEC-205+ cells often surrounded foam cell 
aggregates or, alternatively, were intermingled with foam 
cells (Fig. 3B). Staining with antibody MOMA-2 
demonstrated that most foam cells were of macrophage 
origin. In the deep portion of atherosclerotic plaques, 
DEC-209 cells were often located on the border with 
the media, along the interna1 elastic lamina (Fig. 3C). 
The use of another antibody specific to mouse 
dendritic cells, MIDC-8, showed that MIDC-8+ cells 
were present in al1 the aortas studied. A comparison of 
parallel consecutive sections stained with both DEC-205 
and MIDC-8 antibodies showed that the patterns of 
distribution of DEC-209 cells and those of MIDC-8+ 
cells were similar or nearly identical, which indicated 
that both antibodies stained the same cells (Fig. 4A-D). 
Flg. 2. Distributlon of DEC-205+ cells in atherosclerotic aortas of apoE-deficient mice. A. DEC-205+ cell (arrow) inwrporated within the superficial 
p0rti0n of atherosclerotically altered intima. B. A stellate shaped DEC-205+ cell (arrow) located between elastic fibres in the deep part of the media. C. 
DEC-205+ cell in the adventitia shown by arrow. D. Small arrows show DEG205+ cells attached to the suface of an atherosclerotic plaque while the 
large arrow shows a cluster of DEC-205+ cells attached through fibrin-like material to the surface of the plaque. Note the absence of DEC-205+ cells 
along non-diseased segrnent of the aorta. E. A group of DEC-205+ cells on the surface of an atherosclerotic plaque. L: lumen of the aorta. 
lmrnunoperoxidase technique; visualisation was produced with AEC substrate kit; counterstaining with Mayer's haematoxylin. x 400 
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To see whether DEC-205+/MIDC-8+ cells co- 
localised with lymphocytes in atherosclerotic lesions, 
sets of parallel consecutive sections stained with DEC- 
205, MIDC-8 and anti-CD3 antibodies were compared. 
We found that non-atherosclerotic aortic segments were 
completely free of CD3+ cells and that atherosclerotic 
lesions contained only a few CD3+ cells or did not 
contain this cell type at all. We were not able to establish 
co-localisation between DEC-205+/MIDC-8+ cells and 
rare CD3+ cells. 
Electron-microscopic observations 
We previously obsewed cells with the ultrastructural 
appearance of dendritic cells are present in 
atherosclerotic lesions of apoE-deficient mice 
(Bobryshev et al., 1999b). To ensure that the aortic 
specimens used in the present work contained cells 
exhibiting ultrastructural features typical of dendritic 
cells, electron microscopic analysis was carried out. 
Cells with typical ultrastructural features of dendritic 
cells were detected in atherosclerotic lesions taken from 
al1 the aortas. These ultrastructural features included, in 
particular, the presence of a unique tubulovesicular 
system characteristic of dendritic cells (Lotze and 
Thomson, 1999). Cells containing characteristic cisterns 
of the tubulovesicular system lacked lysosomes and 
phagolysosomes. As the structural characteristics of cells 
exhibiting these features were illustrated and described 
by us in detail earlier (Bobryshev et al., 1999b), the 
electron-microscopic findings are not documented in the 
present report. 
Discussion 
Using an immunohistochemical technique, the 
present study has established the presence of dendritic 
cells in atherosclerotic lesions in apoE-deficient mice. 
This finding is important because apoE-deficient mice 
might provide a useful model for investigating the 
contribution of dendritic cells in atherogenesis. The 
significance of dendritic ceils in atherosclerosis could be 
tested by crossing of apE-deficient mice with dendritic 
cell-deficient mice but the production of dendritic cell- 
Flg. 3. DEC-PO! ills in atherosclerotic plaques of apoEdeficient mice (A-C). In A large arrows show round-shaped DEC-205+ cells attached to the 
luminal surface ,. plaque while small anows indicate DEC-205+ cells spread out along the plaque surface. B shows the distribution of dendritic cells 
(arrows) in a foam cell-rich plaque. The asterisk indicates an area consisting only of foam cells. Note that DEC-205+ cells are not transformed into foam 
cells. C. DEC-205+ cell (arrow) located in the deep portion of the plaque closely attached to the interna1 elastic lamina. 1: intima; M: Media. Star 
indicates a calcification area. L: lumen of the aorta. lmmunoperoxidase technique; visualisation was produced with AEC substrate kit; counterstaining 
with Mayer's haernatoxylin. x 400 
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deficient mice has been hampered because known 
markers for dendritic cells overlapped with the markers 
expressed by other cell types (Lotze and Thomson, 
1999). The recent identification of the genes specifically 
expressed by dendritic cells (Ariizumi et al., 2000) will 
likely facilitate the production of dendritic cell-deficient 
mice and ultimately lead to evaluating the role of 
dendritic cells in atherosclerosis. At present, there are 
severa1 mouse models in which dendritic cell function is 
affected (Lotze and Thomson, 1999). RelB, a member of 
Fig. 4. Parallel consecutive sections (A vs 0; and C vs D) of apoE-deficient mouse aonas stained with either D~L-205 antibody (A and C) or MIDL-8 
antibody (0 and D). Note that the pattems of the distribution of DEC-205+ cells are almost identical to those of MIDC-8+ cells indicating that both 
antibodies stain the same cells. In (A-D), large arrows show DEC-205+/MIDC-8+ cells located in the intima1 layer (A, 0) and in the deep portion of the 
media (C, D). Small arrows identity dot-like DEC-205 or MIDC-8 immunopositive material, presumably corresponding to cross sections of dendritic cell 
processes. L: lumen of the aorta. Immunoperoxidase technique; visualisation was produced with AEC substrate kit; counterstaining with Mayer's 
haematoxylin. x 400 
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the NF-kappaB/Rel family, is highly expressed in 
dendritic cells and RelB-knockout mice (Burkly et al., 
1995; Lotze and Thomson, 1999) can be used for 
crossing with apoE-deficient mice but the interpretation 
of such a crossing might be difficult. 
Atherosclerosis is a chronic inflammatory disease 
with antigen specific T-cell activation (Hansson, 1993; 
Wick et al., 1997; Ross, 1999). T-cell activation depends 
on the interaction of T-cell receptors with antigen 
presented by MHC molecules but how T-cells acquire 
antigens in atherogenesis is still unknown (Hansson, 
1993; Wick et al., 1997; Ross, 1999). The principal 
functions of dendritic cells in other circumstances are 
antigen processing and antigen presentation (Banchereau 
and Steinman, 1998; Lotze and Thomson, 1999) and it is 
most likely that dendritic cells in atherosclerosis 
function sirnilarly. In atherosclerotic lesions, dendritic 
cells probably collect immune-significant information 
and then migrate to regional lymph nodes to present 
antigen to T-cells (Bobryshev and Lord, 1998). Finding 
dendritic cells infiltrating atherosclerotic lesions in 
apoE-deficient mice offers  the possibility of 
investigating the migratory routes of dendritic cells and 
their involvement in T-cell activation. 
Atherosclerosis displays features  of immune 
activation both locally and systemically (Nicoletti et al., 
2000). The immune reactions which take place locally in 
atherosclerotic lesions likely represent only a small 
portion of the immune reactions occurring systemically 
in atherosclerosis (Nicoletti et al., 2000). Although 
mouse atherosclerosis models are useful for 
investigating some aspects of human atherosclerosis, 
mouse atherosclerosis seems not to completely mimic 
the immune-inflammatory aspects of human 
atherosclerosis (Dansky et al., 1997; Nicoletti et al., 
2000). In particular, in contrast to atherosclerosis in man 
where the accumulation of large numbers of both 
macrophages and T-cells in the arterial intima is a 
characteristic of the disease, mouse atherosclerotic 
lesions contain few T-lymphocytes (Dansky et al., 1997). 
The present study demonstrated a low infiltration of T- 
lymphocytes into the aortic wall in apoE-deficient mice. 
If dendritic cells are involved in T-cell activation in 
apoE-deficient mice, this seems not to occur in the 
arterial wall but, mostly likely, occurs in the secondary 
lymphoid organs. 
Severa1 widely different mechanisms appear to lead 
to the development of atherosclerotic lesions. At one end 
of the spectrum are cases depending more or less 
exclusively on high blood cholesterol levels, such as 
hereditary familiar hypercholesterolaemia due to a 
deficiency of LDL-receptors in humans, and similar 
conditions in LDL-receptor-/- or apoE-1- mice. 
Transplant atherosclerosis is mainly T-cell dependant 
and represents the other end of the spectrum. Between 
these extremes there is "common" atherosclerosis, where 
it seems that inflammatory processes start the disease 
and foam cell-rich lesions plaques develop later. 
Mouse atherosclerosis cannot completely mimic the 
immune-inflammatory aspects of human atherosclerosis 
because the normal arterial wall in mice lacks a cell-rich 
intima, unlike this important structural feature of human 
arteries. The present study demonstrated that the non- 
diseased aortic intima in apoE-deficient mice is free of 
dendritic cells. In man, in contrast to mice, vascular 
dendritic cells seem to reside in the intima of normal 
non-diseased arteries and become activated during 
atherogenesis (Bobryshev and Lord, 1995; Bobryshev et 
al., 1997; Bobryshev and Watanabe, 1997; Lord and 
Bobryshev, 1999; Bobryshev 2000). 
Dendritic cells observed in the atherosclerotically 
altered intima in apoE-deficient mice probably originate 
from blood dendritic cells. In man, during plaque 
formation, in addition to vascular dendritic cells resident 
in the normal arterial wall, blood dendritic cells may 
also infiltrate from the blood (Bobryshev and Lord, 
1998; Bobryshev et al., 1999~).  The frequent location of 
dendritic cells within areas of neovascularisation and 
within the lumen of microvessels in human 
atherosclerotic plaques favours the possibility that in 
man, blood dendritic cells might penetrate plaques 
through neovascularisation (Bobryshev and Lord, 1998; 
Bobryshev et al., 1999~) .  Using apoE-deficient mouse 
might help resolve this issue as in vivo transfer of 
labelled dendritic cells could help trace the migratory 
routes of dendritic cells. Murine knockout models have 
provided and stil l  afford important clues in 
understanding atherogenesis, but it is certain that the 
results cannot be directly transferable to those events 
leading to "common" atherosclerosis in humans. 
Investigating vascular dendritic cells residing in normal 
human arteries will require a search for other models and 
other approaches. 
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